Target intelligence / Profile preview

Tumor Protein p53 Y220C Mutant (p53 Y220C)

Target
p53 Y220C
Molecular classification
Transcription factor, Tumor suppressor
01

Overview

Tumor protein p53, encoded by the TP53 gene, is a critical tumor suppressor that regulates cell division and prevents uncontrolled cell proliferation. It acts as a transcription factor, binding to DNA and activating genes involved in DNA repair, cell cycle arrest, apoptosis (programmed cell death), and other protective cellular responses. The Y220C mutation is a substitution of tyrosine with cysteine at position 220 within the DNA-binding domain. This mutation creates a hydrophobic cavity that destabilizes the protein, impairing DNA binding and tumor suppression. The unique surface cavity created by Y220C provides an opportunity for targeted drug design: small molecules can bind this crevice to stabilize mutant p53’s structure.

Other names
TP53 Y220Cp53-Y220CY220C p53p53 with Y220C mutation
02

Mechanism of action

Small molecule stabilization of mutant protein structure.

03

Biological functions

Cell cycle regulationApoptosisDNA repairTumor suppressionTranscriptional regulation
04

Disease associations

Cancer
05

Safety considerations

Potential for off-target effects of small molecule stabilizersDevelopment of resistance to small molecule stabilizers
06

Biomarkers

Y220C mutation in TP53 gene

Beyond the preview

Go deeper on Tumor Protein p53 Y220C Mutant (p53 Y220C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Protein p53 Y220C Mutant (p53 Y220C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call